A new study suggests that GLP-1 agonist medications like Ozempic, which are used for diabetes management and weight loss, may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders. "These medications intended for diabetes and weight loss can help addiction without the associated stigma, which will be a new window for how to deal with addiction." GLP-1 drugs, such as Ozempic and the combination drug tirzepatide also included in the study, mimic a natural hormone known as glucagon-like peptide-1 to help regulate blood sugar and insulin levels. People with substance use disorder keep using drugs or alcohol even though it causes problems in their life. Weight loss drugs like Ozempic may help reduce overdose risks: Study originally appeared on abcnews.go.com

Source: ABC News October 17, 2024 11:44 UTC